1349-7006/asset/cas_centre.gif?v=1&s=11108c6693d2a39ca49ee937260cc26f94293b0d)
1349-7006/asset/cas_right.gif?v=1&s=8b26cd26c2b4c8264011a9ddc0ed1cf4aaee0b20)
You have free access to this content
Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma
Article first published online: 19 MAY 2010
DOI: 10.1111/j.1349-7006.2010.01622.x
© 2010 Japanese Cancer Association
Additional Information
How to Cite
Iwakawa, R., Kohno, T., Enari, M., Kiyono, T. and Yokota, J. (2010), Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma. Cancer Science, 101: 1891–1896. doi: 10.1111/j.1349-7006.2010.01622.x
Publication History
- Issue published online: 20 JUL 2010
- Article first published online: 19 MAY 2010
- (Received March 11, 2010/Revised April 28, 2010/Accepted April 30, 2010/Accepted manuscript online May 19, 2010/Article first published online June 14, 2010)
References
- 1. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009; 384: 260–5.
- 2, , . Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76–9.
- 3, , , , . The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129–36.
- 4, , et al. Whole genome comparison of allelic imbalance between noninvasive and invasive small-sized lung adenocarcinomas. Cancer Res 2009; 69: 1615–23.
- 5, , . Lung cancer in never smokers--a different disease. Nat Rev Cancer 2007; 7: 778–90.
- 6, , . Incidence of human papilloma virus in lung cancer. Lung Cancer 2009; 65: 13–8.
- 7, , . Human papillomavirus type 16 and 18 in primary lung cancers--a meta-analysis. Carcinogenesis 2009; 30: 1722–8.
- 8, , et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 2001; 61: 2799–803.
- 9, , et al. Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China. Jpn J Clin Oncol 2006; 36: 274–9.
- 10, , et al. The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients. Yonsei Med J 2007; 48: 69–77.
- 11, , , , , . Human papillomavirus DNA in squamous cell carcinoma of the lung. J Clin Pathol 1996; 49: 810–7.
- 12, , et al. Extremely high Langerhans cell infiltration contributes to the favourable prognosis of HPV-infected squamous cell carcinoma and adenocarcinoma of the lung. Histopathology 2001; 38: 355–67.
- 13, , et al. Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung. Br J Cancer 1995; 71: 344–9.
- 14, , et al. Ultrastructural study of intranuclear inclusion bodies of pulmonary adenocarcinoma. Ultrastruct Pathol 1999; 23: 383–9.
- 15SobinLH, WittekindCH, eds. TNM classification of malignant tumours, 6th ed. New York: Wiley-Liss; 2002: p. 99–103.
- 16, , et al. Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. Proc Natl Acad Sci U S A 1986; 83: 3997–4001.
- 17, , et al. A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene. Genes Chromosomes Cancer 2010; 49: 342–52.
- 18, , et al. A gene-alteration profile of human lung cancer cell lines. Hum Mutat 2009; 30: 1199–206.
- 19, , et al. Genotyping of Human Papillomaviruses by a Novel One-Step Typing Method with Multiplex PCR and Clinical Applications. J Clin Microbiol 2008; 46: 1161–8.
- 20, , et al. Evaluation of high-risk human papillomaviruses type distribution in cervical cancer in Sichuan province of China. BMC Cancer 2008; 8: 202.
- 21, , et al. Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma. Oncogene 1999; 18: 1007–14.
- 22, , et al. Association of p16 homozygous deletions with clinicopathological characteristics and EGFR/KRAS/p53 mutations in lung adenocarcinoma. Clin Cancer Res 2008; 14: 3746–53.
- 23, , et al. Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene 2007; 26: 5911–8.
- 24, , et al. COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res 2010; 38(Database issue): D652–7.
- 25, , et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985; 314: 111–4.
- 26, , , , , . Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 1987; 61: 962–71.
- 27, , , , . Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 1985; 119: 361–6.
- 28, , et al. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res 1989; 49: 3598–601.
- 29, , et al. Deletion mapping of chromosome 3p in human uterine cervical cancer. Oncogene 1993; 8: 1825–32.
- 30, . Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol 2007; 212: 356–67.
- 31, , , , . Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination. Cancer Biol Ther 2008; 7: 699–708.
- 32, , et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 2007; 28: 622–9.
- 33, , . Occurrence of human papillomavirus DNA in primary lung neoplasms. Cancer 1992; 69: 693–7.
- 34, , et al. Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects. JAMA 1998; 279: 1554–9.
- 35, , et al. RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma. Oncogene 1994; 9: 2441–8.
- 36, , et al. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res 2007; 67: 10686–93.
- 37, , et al. Human papillomavirus type 16 and 18 infection is associated with lung cancer patients from the central part of China. Oncol Rep 2008; 2: 333–9.